The Meghalayan Medical Drugs & Services Limited (MMDSL) on Thursday said quality test report confirmed that the Albendazole tablets are meeting the standard quality criteria and there has been no adverse effect reported in the state.
In a shocking finding, the Regional Drug Testing Laboratory (RDTL) in Guwahati reported that two medicines purchased by the Directorate of Health Services (MI) of Meghalaya are substandard and not fit for consumption by the patients.
